Through allocations, Baxter is limiting how much customers can order based on their past purchases, medical necessity and ...

The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

A decade into reformulating Pfizer’s oral renal cell carcinoma drug Inlyta (axitinib) into a treatment that can be injected ...

Treatments for multiple sclerosis have long focused on slowing or stopping the acute disease process, which moves quickly and ...

A trial of Biogen’s spinal muscular atrophy (SMA) therapy Spinraza (nusinersen) suggests that a higher dose provides benefits ...

After third-party manufacturing issues led to a December rejection of Zealand Pharma’s pediatric congenital hyperinsulinism (CHI) candidate, the Danish pharma’s latest snub seems to come down to ti | ...

Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...

The Congressional Budget Office found that only one out of the seven policies it reviewed would create notable reductions in ...

A new survey commissioned by Big Pharma Roche has found that half of those polled “have either limited or no awareness” of ...